NN, Inc. Acquires Paragon Medical

We represented NN, Inc. (Nasdaq: NNBR) in the acquisition of Paragon Medical, a private equity backed medical device manufacturer, for $375 million. Paragon Medical focuses on the orthopedic, case and tray, implant and instrument markets.

NN, Inc., a diversified industrial company combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. NN has 51 facilities in North America, Western Europe, Eastern Europe, South America and China.

This transaction was named a winner in the “Healthcare and Life Sciences Deal of the Year (Over $100MM-$1B)” category at the 17th Annual M&A Advisor Awards in 2018. It had been recognized as a Finalist, along with three other deals involving Bass, Berry & Sims, for the 2018 M&A Advisor Awards.

This deal also was recognized by Global M&A Network at the 2018 M&A Atlas Awards as the USA M&A Deal of the Year – Middle Market Segment.

You Also May Be Interested In:

  • We represented SERVPRO in its recapitalization transaction, in partnership with Blackstone, one of the world’s leading investment firms. Blackstone is...
    Client Type: Private Company
  • We represented nutritional supplement manufacturing company, Natural Alternatives International, Inc. (Nasdaq: NAII), in a Federal Circuit Court of Appeals case in which our client had brought claims against rival Creative Compounds LLC, accusing Creative Compounds of infringing six of its patents covering various forms of beta-alanine and its use as a muscle-building supplement.  The Southern District of California had dismissed the suit, finding the patent claims to be directed toward a product of nature (beta-alanine) and a law of nature (that taking beta-alanine in sufficient quantities builds muscle) and thus patent-ineligible.  On appeal, a split panel sided with our client, finding the district court applied too broadly the ineligibility doctrine of the “Alice/Mayo test” and that, although beta-alanine itself can occur as a natural substance, the claims containing beta-alanine as one aspect covered more than an unpatentable natural law.

    Law360 provided analysis of the case in the article “Fed. Circ. Clarifies Alice In Reviving Supplement Co.’s IP Suit,” published on March 15, 2019.

    We represented nutritional supplement manufacturing company, Natural Alternatives International, Inc. (Nasdaq: NAII), in a Federal Circuit Court of Appeals case...
    Client Type: Public Company
  • Co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate of Need (CON) to initiate radiation therapy at its hospital campus located in Germantown, Tennessee

    Bass, Berry & Sims served as co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate...
    Client Type: Nonprofit